- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Development of nasal HPV vaccine formulations ; volume:02 ; number:S 01 ; year:2016 ; 01
Konferenz: 16th Annual International Conference RGCON; 2017-02-03; Habitat World, India habitat Centre, Delhi
Asian Journal of Oncology ; 02, Heft S 01 (2016), 01
- Contributor
-
Krishnakumar, D.
Jaganathan, K. S.
- DOI
-
10.1055/s-0039-1685403
- URN
-
urn:nbn:de:101:1-2019090911101035343130
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Krishnakumar, D.
- Jaganathan, K. S.
Other Objects (12)
Perspectives for therapeutic HPV vaccine development
Development of vaccine formulations: past, present, and future
Stabilisation and characterisation of protein and vaccine formulations
Stabilisation and characterisation of protein and vaccine formulations
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Effects of excipients in nasal powder formulations for systemic drug delivery
Individual- and Regional-level determinants of Human Papillomavirus (HPV) vaccine refusal: the Ontario Grade 8 HPV vaccine cohort study
Disparities in HPV vaccine knowledge and adolescent HPV vaccine uptake by parental nativity among diverse multiethnic parents in New Jersey
In-depth immunological analysis of prototypic adjuvants for vaccine formulations
Nasal Powder Formulations : In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects
Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice
Meta-analysis of correlates of HPV vaccine acceptability among men: supporting vaccine implementation science
Perspectives for therapeutic HPV vaccine development
Development of vaccine formulations: past, present, and future
Stabilisation and characterisation of protein and vaccine formulations
Stabilisation and characterisation of protein and vaccine formulations
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Effects of excipients in nasal powder formulations for systemic drug delivery
Individual- and Regional-level determinants of Human Papillomavirus (HPV) vaccine refusal: the Ontario Grade 8 HPV vaccine cohort study
Disparities in HPV vaccine knowledge and adolescent HPV vaccine uptake by parental nativity among diverse multiethnic parents in New Jersey
In-depth immunological analysis of prototypic adjuvants for vaccine formulations
Nasal Powder Formulations : In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects
Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice
Meta-analysis of correlates of HPV vaccine acceptability among men: supporting vaccine implementation science
Perspectives for therapeutic HPV vaccine development
Development of vaccine formulations: past, present, and future
Stabilisation and characterisation of protein and vaccine formulations
Stabilisation and characterisation of protein and vaccine formulations
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Effects of excipients in nasal powder formulations for systemic drug delivery
Individual- and Regional-level determinants of Human Papillomavirus (HPV) vaccine refusal: the Ontario Grade 8 HPV vaccine cohort study
Disparities in HPV vaccine knowledge and adolescent HPV vaccine uptake by parental nativity among diverse multiethnic parents in New Jersey
In-depth immunological analysis of prototypic adjuvants for vaccine formulations
Nasal Powder Formulations : In-Vitro Characterisation of the Impact of Powders on Nasal Residence Time and Sensory Effects
Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice